INBRAIN Neuroelectronics

INBRAIN Neuroelectronics S.L., founded in 2019, is a medical device company dedicated to developing the world's first intelligent graphene-brain interface for the treatment of various diseases. INBRAIN's first product aims to read and modulate brain activity, using artificial intelligence to trigger adaptive responses, providing personalized neurotherapies for epilepsy and Parkinson's disease.